LifeCell Corporation

LifeCell is now an Acelity company! Acelity is a global market leader in advanced wound therapeutics and regenerative medicine, offering innovative solutions from the hospital to home that improve the lives of patients in more than 80 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients' lives. We are the undisputed leader in negative pressure wound therapy, the number one provider of regenerative tissue products used for breast reconstruction and hernia repair, and the market leader in collagen dressings. Acelity is headquartered in San Antonio, Texas, with more than 5,800 employees around the globe. LifeCell is focused on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in general and reconstructive surgical procedures to repair soft tissue defects, as well as autologous fat grafting solutions. The LifeCell portfolio began with ALLODERM™ Regenerative Tissue Matrix, which launched in 1994, and expanded with the launch of STRATTICE™ Reconstructive Tissue Matrix in 2008, the same year that Kinetic Concepts, Inc. (KCI) acquired LifeCell. In 2012, LifeCell further expanded its portfolio with the launch of ALLODERM™ Ready to Use. In June 2013, LifeCell introduced the REVOLVE™ System to offer fast and efficient fat transfer processing for use in a range of aesthetic and reconstructive procedures. In 2014, KCI's parent company announced that KCI, LifeCell and Systagenix would operate under one global medical technology brand known as Acelity.